Do You Routinely Monitor Patients for Signs of Leukemic Transformation (eg, JAK2 Allele Burden)?
Dr. John Mascarenhas, Mt. Sinai School of Medicine, answers the following questions: Do you routinely monitor patients for signs of leukemic transformation (eg, JAK2 allele burden)? Typically, what are early signs of clinical disease progression?
Recent Video
Most Popular
Specialties :                    Search : is a member of the Oncology.TV family of oncology medical education websites. offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).